免疫疗法
医学
表观遗传学
癌症免疫疗法
临床试验
表观遗传疗法
癌症
免疫系统
肿瘤科
免疫检查点
免疫学
生物信息学
DNA甲基化
内科学
生物
基因表达
基因
生物化学
作者
Michael J. Topper,Michelle Vaz,Kristen A. Marrone,Julie R. Brahmer,Stephen B. Baylin
标识
DOI:10.1038/s41571-019-0266-5
摘要
The past decade has seen the emergence of immunotherapy as a prime approach to cancer treatment, revolutionizing the management of many types of cancer. Despite the promise of immunotherapy, most patients do not have a response or become resistant to treatment. Thus, identifying combinations that potentiate current immunotherapeutic approaches will be crucial. The combination of immune-checkpoint inhibition with epigenetic therapy is one such strategy that is being tested in clinical trials, encompassing a variety of cancer types. Studies have revealed key roles of epigenetic processes in regulating immune cell function and mediating antitumour immunity. These interactions make combined epigenetic therapy and immunotherapy an attractive approach to circumvent the limitations of immunotherapy alone. In this Review, we highlight the basic dynamic mechanisms underlying the synergy between immunotherapy and epigenetic therapies and detail current efforts to translate this knowledge into clinical benefit for patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI